Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Research

Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials

Ryan Zarychanski, Alexis F. Turgeon, Lauralyn McIntyre and Dean A. Fergusson
CMAJ September 25, 2007 177 (7) 725-734; DOI: https://doi.org/10.1503/cmaj.071055
Ryan Zarychanski MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexis F. Turgeon MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauralyn McIntyre MD MHSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dean A. Fergusson MHA PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 1: Selection of studies for meta-analysis.

  • Figure2
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 2: Analysis of mortality in selected trials of erythropoietin use in critially ill patients. Note: EPO = erythropoietin, CI = confidence interval.

  • Figure3
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 3: Mortality sensitivity analysis of studies included in the meta-analysis of erythropoietin use in critically ill patients. Note: CI = confidence interval.

  • Figure4
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 4: Analysis of transfusion independence among critically ill patients who received erythropoietin or control (placebo or no intervention). EPO = erythropoietin, CI = confidence interval.

Tables

  • Figures
  • Table 1.

    Table1
  • Table 2.

    Table2
  • Table 3.

    Table3
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 177 (7)
CMAJ
Vol. 177, Issue 7
25 Sep 2007
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials
Ryan Zarychanski, Alexis F. Turgeon, Lauralyn McIntyre, Dean A. Fergusson
CMAJ Sep 2007, 177 (7) 725-734; DOI: 10.1503/cmaj.071055

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials
Ryan Zarychanski, Alexis F. Turgeon, Lauralyn McIntyre, Dean A. Fergusson
CMAJ Sep 2007, 177 (7) 725-734; DOI: 10.1503/cmaj.071055
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Interpretation
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Indication creep: physician beware
  • L'expansion des indications : médecins, attention
  • Highlights of this issue
  • Dans ce numéro
  • Erythropoietin use in critically ill patients: forest and trees
  • PubMed
  • Google Scholar

Cited By...

  • Anemia, Bleeding, and Blood Transfusion in the Intensive Care Unit: Causes, Risks, Costs, and New Strategies
  • Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation
  • Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response?
  • Erythropoietic agents for anemia of critical illness
  • Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients
  • Corticosteroids and erythropoeitin-receptor agonists
  • L'expansion des indications : medecins, attention
  • Indication creep: physician beware
  • Erythropoietin use in critically ill patients: forest and trees
  • Google Scholar

More in this TOC Section

  • Physician choices in pulmonary embolism testing
  • Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta
  • Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study
Show more Research

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire